by admin | Dec 5, 2025 | press-releases
Home PRESS RELEASE New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO...
by admin | Nov 25, 2025 | press-releases
Home PRESS RELEASE CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 26th Annual Meeting π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER...
by admin | Apr 26, 2025 | press-releases
Home PRESS RELEASE CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at the American Urological Association Annual Meeting π» DESKTOP AUDIO PLAYER...
by admin | Apr 24, 2025 | press-releases
Home PRESS RELEASE CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Monday, April 28, 2025 π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to...
by admin | Mar 31, 2025 | press-releases
Home PRESS RELEASE CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER...
by admin | Mar 28, 2025 | press-releases
Home PRESS RELEASE CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates π» DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 π± MOBILE AUDIO PLAYER =============================== --> Listen to this...